Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice.

Aguilaniu B, Gonzalez-Bermejo J, Regnault A, Barbosa CD, Arnould B, Mueser M, Granet G, Bonnefoy M, Similowski T.

Int J Chron Obstruct Pulmon Dis. 2011;6:387-98. doi: 10.2147/COPD.S20007. Epub 2011 Jul 5.

2.

Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: the ELSIE study.

Lim R, Sun Y, Im SA, Hsieh RK, Yau TK, Bonaventura A, Cheirsilpa A, Esser R, Mueser M, Advani S.

World J Gastroenterol. 2011 Apr 14;17(14):1879-88. doi: 10.3748/wjg.v17.i14.1879.

3.

[The profile of the patients referred by general practitioners to respiratory physicians for assessment of undiagnosed bronchial disease].

Escamilla R, Grignet JP, Bourcereau J, Mueser M.

Rev Mal Respir. 2010 May;27(5):463-71. doi: 10.1016/j.rmr.2010.03.007. French.

PMID:
20569879
4.

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O'Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M, Gatzemeier U; FLEX Study Team..

Lancet. 2009 May 2;373(9674):1525-31. doi: 10.1016/S0140-6736(09)60569-9.

PMID:
19410716
5.

Pharmacokinetic profile of cetuximab (Erbitux) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma.

Delbaldo C, Pierga JY, Dieras V, Faivre S, Laurence V, Vedovato JC, Bonnay M, Mueser M, Nolting A, Kovar A, Raymond E.

Eur J Cancer. 2005 Aug;41(12):1739-45.

PMID:
16051481
6.

Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.

Chan AT, Hsu MM, Goh BC, Hui EP, Liu TW, Millward MJ, Hong RL, Whang-Peng J, Ma BB, To KF, Mueser M, Amellal N, Lin X, Chang AY.

J Clin Oncol. 2005 May 20;23(15):3568-76. Epub 2005 Apr 4.

PMID:
15809453
7.

[The "Compli'Asthme" therapeutic observation survey on good use of inhaled drugs for asthma: perception by general practitioners].

Megas F, Benmedjahed K, Lefran├žois G, Mueser M, Dusser D.

Rev Pneumol Clin. 2004 Jun;60(3):158-65. French.

PMID:
15292825
8.

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E.

N Engl J Med. 2004 Jul 22;351(4):337-45.

Supplemental Content

Loading ...
Support Center